Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Omer M, Saad M, Willson L, Monyak DJ, Sullivan P, Pershad A, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine 2020, 23: 28-35. PMID: 32883584, DOI: 10.1016/j.carrev.2020.08.035.Peer-Reviewed Original ResearchConceptsTarget vessel revascularizationIncidence of TVRIncidence of MIRecurrent ISRMyocardial infarctionCause mortalityStent restenosisSystematic reviewIntravascular brachytherapyOutcomes of interestVessel revascularizationCoronary DrugObservational studyMeta-AnalysisIncidencePrevious treatmentBrachytherapyTwo yearsPatientsRestenosisMortalityStentsOutcomesTreatmentLimited studies